GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » FCF Margin %

No.25 Central Pharmaceutical JSC (HSTC:UPH) FCF Margin % : 0.00% (As of . 20)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. No.25 Central Pharmaceutical JSC's Free Cash Flow for the six months ended in . 20 was ₫0.00 Mil. No.25 Central Pharmaceutical JSC's Revenue for the six months ended in . 20 was ₫0.00 Mil. Therefore, No.25 Central Pharmaceutical JSC's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, No.25 Central Pharmaceutical JSC's current FCF Yield % is 0.00%.

The historical rank and industry rank for No.25 Central Pharmaceutical JSC's FCF Margin % or its related term are showing as below:


HSTC:UPH's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.89
* Ranked among companies with meaningful FCF Margin % only.


No.25 Central Pharmaceutical JSC FCF Margin % Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC FCF Margin % Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
FCF Margin %

No.25 Central Pharmaceutical JSC Semi-Annual Data
FCF Margin %

Competitive Comparison of No.25 Central Pharmaceutical JSC's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, No.25 Central Pharmaceutical JSC's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


No.25 Central Pharmaceutical JSC's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, No.25 Central Pharmaceutical JSC's FCF Margin % distribution charts can be found below:

* The bar in red indicates where No.25 Central Pharmaceutical JSC's FCF Margin % falls into.



No.25 Central Pharmaceutical JSC FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

No.25 Central Pharmaceutical JSC's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

No.25 Central Pharmaceutical JSC's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


No.25 Central Pharmaceutical JSC FCF Margin % Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


No.25 Central Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines